Kopala L., Smith G., Malla A., Williams S., Love L., Talling D., Balshaw R. (2006). Resource utilization in a Canadian national study of people with schizophrenia and related psychotic disorders, Acta Psychiatr Scand Suppl(430), 29-39.

Lal S., Thavundayil J. X., Nair N., Annable L., Ng Ying Kin N. M., Gabriel A., Schwartz G. (2006). Levomepromazine versus chlorpromazine in treatment-resistant schizophrenia: a double-blind randomized trial , J Psychiatry Neurosci (pp. 271-279). CMA Media Inc..

Lord C., Buss C., Lupien S. J., Pruessner J. (2006). Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users and men: A possible window of opportunity effect, Neurobiol Aging.

Ma W., Chabot J. G., Quirion R. (2006). A role for adrenomedullin as a pain-related peptide in the rat, Proc Natl Acad Sci U S A, 103(43), 16027-32.

Ma W., Quirion R. (2006). Increased calcitonin gene-related peptide in neuroma and invading macrophages is involved in the up-regulation of interleukin-6 and thermal hyperalgesia in a rat model of mononeuropathy, J Neurochem, 98(1), 180-92.

Ma W., Quirion R. (2006). Targeting invading macrophage-derived PGE2, IL-6 and calcitonin gene-related peptide in injured nerve to treat neuropathic pain, Expert Opin Ther Targets, 10(4), 533-46.

Malla A., Williams S., Kopala L., Smith G., Talling D., Balshaw R. (2006). Outcome on quality of life in a Canadian national sample of patients with schizophrenia and related psychotic disorders, Acta Psychiatr Scand Suppl(430), 22-8.

Marinelli P. W., Lam M., Bai L., Quirion R., Gianoulakis C. (2006). A microdialysis profile of dynorphin a release in the rat nucleus accumbens following alcohol administration, Alcohol Clin Exp Res, 30(6), 982-90.

Peters K. R., Rockwood K., Black S. E., Bouchard R., Gauthier S., Hogan D., Kertesz A., Loy-English I., Beattie B. L., Sadovnick A. D., Feldman H. H. (2006). Characterizing neuropsychiatric symptoms in subjects referred to dementia clinics, Neurology, 66(4), 523-8.

Quirion R. (2006). Tea leaves Alzheimer's disease behind, Healthc Q, 9(3), 21-2.

Rajah M., McIntosh A. R. (2006). Dissociating prefrontal contributions during a recency memory task, Neuropsychologia, 44(3), 350-64.

Reix S., Mechawar N., Susin S. A., Quirion R., Krantic S. (2006). Expression of cortical and hippocampal apoptosis-inducing factor (AIF) in aging and Alzheimer's disease, Neurobiol Aging.

Rowe W. B., Kar S., Meaney M., Quirion R. (2006). Neurotensin receptor levels as a function of brain aging and cognitive performance in the Morris water maze task in the rat, Peptides, 27(10), 2415-23.

Seeman P., Schwarz J., Chen J. F., Szechtman H., Perreault M., McKnight G. S., Roder J. C., Quirion R., Boksa P., Srivastava L., Yanai K., Weinshenker D., Sumiyoshi T. (2006). Psychosis pathways converge via D2(High) dopamine receptors, Synapse, 60(4), 319-346.

Smith G., Malla A., Williams S., Kopala L., Love L., Balshaw R. (2006). The Canadian National Outcomes Measurement Study in Schizophrenia: overview of the patient sample and methodology, Acta Psychiatr Scand Suppl(430), 4-11.

Takhshid M. A., Poyner D. R., Chabot J. G., Fournier A., Ma W., Zheng W. H., Owji A. A., Quirion R. (2006). Characterization and effects on cAMP accumulation of adrenomedullin and calcitonin gene-related peptide (CGRP) receptors in dissociated rat spinal cord cell culture, Br J Pharmacol, 148(4), 459-68.

Teipel S. J., Pruessner J., Faltraco F., Born Ch, Rocha-Unold M., Evans A., Moller H. J., Hampel H. (2006). Comprehensive dissection of the medial temporal lobe in AD: measurement of hippocampus, amygdala, entorhinal, perirhinal and parahippocampal cortices using MRI, J Neurol, 253(6), 794-800.

Thiffault I., Rioux M. F., Tetreault M., Jarry J., Loiselle L., Poirier J., Gros-Louis F., Mathieu J., Vanasse M., Rouleau G. A., Bouchard J. P., Lesage J., Brais B. (2006). A new autosomal recessive spastic ataxia associated with frequent white matter changes maps to 2q33-34, Brain.

Touchon J., Portet F., Gauthier S. (2006). Prevention trials in Alzheimer disease: One step forward?, Neurology, 67(9 Suppl 3), S21-2.

Williams S., Kopala L., Malla A., Smith G., Love L., Balshaw R. (2006). Medication decisions and clinical outcomes in the Canadian National Outcomes Measurement Study in Schizophrenia, Acta Psychiatr Scand Suppl(430), 12-21.